Literature DB >> 5521408

A new method for determination of insulin-binding immunoglobulins in insulin-treated diabetic patients.

A H Christiansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5521408     DOI: 10.1055/s-0028-1096808

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  12 in total

1.  Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.

Authors:  A J Scheen; J Gillet; J Rosenthaler; J Guiot; P Henrivaux; B Jandrain; P J Lefèbvre
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

2.  [Quantitative determination of aqueous humor proteins by electroimmodiffusion in an antiserum containing agarosegel (author's transl)].

Authors:  M Zirm; W Petek; O Schmut; H Hofmann; A Holasek
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-08-06

Review 3.  Circulating insulin-binding antibodies.

Authors:  A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

4.  Fibrinolysis and peritoneal dialysis in the treatment of diabetic coma, complicated by severe shock. A case report.

Authors:  H Nobis; M Fischer; F S Fuchs; W Korp
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

5.  Urinary zinc and its relationships with microalbuminuria in type I diabetics.

Authors:  J F Brun; C Fons; M Fussellier; L Bardet; A Orsetti
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

6.  The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.

Authors:  U Di Mario; L Ventriglia; M Iavicoli; K Guy; D Andreani
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

7.  Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purity.

Authors:  M Iavicoli; L Ventriglia; U Di Mario; C Galfo; D Andreani
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

8.  Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control.

Authors:  J C Daubresse; A Bailly; C Lemy; J C Meunier; A S Luyckx; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1980 Jul-Dec

9.  Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies.

Authors:  F Sodoyez-Goffaux; M Koch; N Dozio; D Brandenburg; J C Sodoyez
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

10.  Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.

Authors:  B Weber; J Tech; H Schmidt; U Oberdisse
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.